IFS Group’s Amgen AMGN Stock Holding History

IFS Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$230K	Buy	+771	New	+$224K	0.2%	128

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IFS Group's AMGN Position: Q3 2025 in Review

IFS Group opened a new position in Amgen (AMGN) in Q3 2025: 771 shares worth $230K. The stake represents 0.2% of the portfolio and ranks #128 among its holdings.

2,826 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

IFS Group held 771 shares of Amgen worth $230K as of Q3 2025.
Amgen was a new IFS Group position in Q3 2025.
Amgen made up 0.2% of IFS Group's portfolio in Q3 2025, its #128 holding.
2,826 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on IFS Group's 13F filing for Q3 2025, filed 10 Nov 2025.